-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Has Lifted The Clinical Hold On GH Research's Investigational New Drug Application For GH001, Phase 3 Initiation Targeted For 2026

Benzinga·01/05/2026 12:12:08
語音播報
  • GH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollment
  • Company to seek FDA alignment on global Phase 3 program replicating Phase 2b design
  • Phase 3 initiation targeted for 2026